- Chiariho malformation without myelodysplasia. Experience with treatment in 50 patients2004 | Faculty of Physical Education and Sport
- Chiariho malformation without myelodysplasia. Experience with treatment in 50 patients2004 | First Faculty of Medicine
- Surgical Treatment of 50 PTs with Chiari Malformation without MyelodysplasiaPublication without faculty affiliation
- Treatment of relapsed myeloma with secondary myelodysplasia - a case report2013 | First Faculty of Medicine
- Chiari Malformation without Myelodysplasia. Surgical Treatment of 50 CasesPublication without faculty affiliation
- Up-regulation of ribosomal genes is associated with a poor response to azacitidine in myelodysplasia and related neoplasms2016 | Publication without faculty affiliation
- Combined immunosupressive treatment in patients with early myelodysplasiaPublication without faculty affiliation
- TRAIL/Apo2L/ supresses growth of primary human leukemia and myelodysplasia progenitors2002 | First Faculty of Medicine
- TRAIL/Apo2L/ supresses growth of primary human leukemia and myelodysplasia progenitors2002 | Faculty of Physical Education and Sport
- TRAIL/APO2L inhibits myelodysplasia and myeloid leukemia progenitor growth while it does not affect normal progenitors in vitro and normal CD34+ cell repopulation in NOD/SCID micePublication without faculty affiliation
- Chiariho malformacion without myelodysplasia. Surgical treatment of 40 cases. Syringo/- hydromyeliePublication without faculty affiliation
- Relationship between Altered miRNA Expression and DNA Methylation of the DLK1-DIO3 Region in Azacitidine-Treated Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia with Myelodysplasia-Related Changes2018 | Publication without faculty affiliation
- Simultaneous Cerebral and Spinal Fluid Pressure Recordings in Surgical Indications of the Chiari Malformation without Myelodysplasia2001 | First Faculty of Medicine
- A limited impact of chemotherapy on prolonged survival in myelodysplasia (MDS) : an analysis of 142 patients with advanced diseasePublication without faculty affiliation
- Noncoding RNAs and Their Response Predictive Value in Azacitidine-treated Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia With Myelodysplasia-related Changes2022 | Central Library of Charles University
- The Treatment of anemia - 2nd Part2007 | First Faculty of Medicine
- A comparative study of deferasirox and deferiprone in the treatment of iron overload in patients with myelodysplastic syndromes2013 | Publication without faculty affiliation
- Transplant results in adults with Fanconi anaemia2018 | Second Faculty of Medicine
- The presence of clonal cell populations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia2005 | First Faculty of Medicine
- The presence of clonal cell populations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia2005 | Faculty of Physical Education and Sport
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | First Faculty of Medicine
- Efficacy and safety of administration of oral iron chelator deferiprone in patients with early myelodysplastic syndrome2011 | Publication without faculty affiliation
- Recurrent skin eruption in patient with chronic lymphocytic leukemia and lymphocytic infiltrates of the dermis resembling Sweet's syndrome2011 | Second Faculty of Medicine
- Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study2014 | Publication without faculty affiliation
- MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia2018 | Publication without faculty affiliation
- The variable biological signature of refractory cytopenia of childhood (RCC), a retrospective EWOG-MDS study2021 | Second Faculty of Medicine
- Experiences on MDS and JMML from the EWOG-MDS2003 | Second Faculty of Medicine
- Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34(+) Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients2021 | First Faculty of Medicine
- Allogeneic stem cell transplantation can improve outcome of AML patients without complete cytogenetic response after induction and consolidation treatment2015 | Faculty of Medicine in Pilsen
- Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome2016 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové